Provost Miriam
Officer at TMDX
- Sold, on record
- $1.1M
- Dollars the filings state
- Form 4 sales
- 5
- Latest Dec 13, 2023
- Form 144 notices
- 4
- Proposed sales
- Companies
- 1
- Filed as an executive or holder
Companies
- TMDXTransMedics Group, Inc.Officer
Sales by reason
Form 4 sales per month, last 12 months.
Timeline
- 1 Form 4 sale TMDXPlan not statedDec 9, 2022 2022
Sold 3,613 shares at $59.00 ($213k)
Provost Miriam, VP, Global Regulatory Affairs
Sold 21% of holdings ($1M position)13,551 shares leftFiling
- 2 Form 4 sale TMDXPlan not statedDec 13, 2022 +4 days
Sold 4,315 shares at $62.53 ($270k)
Provost Miriam, VP, Global Regulatory Affairs
Sold 22.2% of holdings ($1.2M position)15,154 shares leftFiling
- 3 Form 144 notice TMDXNoticeAug 31, 2023 +261 days
Filed to sell 2,708 shares ($180k)
Provost Miriam, Officer
No 10b5-1 plan0.7x usual sizeFiling
- 4 Form 4 sale TMDXNo planAug 31, 2023 same day
Sold 2,708 shares at $66.52 ($180k)
Provost Miriam, VP, Global Regulatory Affairs
No 10b5-1 planSold 10.3% of holdings ($1.8M position)23,611 shares left0.7x usual sizeFollows a Form 144Filing
- 5 Form 144 notice TMDXNoticeDec 13, 2023 +104 days
Filed to sell 4,122 shares ($310k)
Provost Miriam, Officer
No 10b5-1 plan1.1x usual sizeFiling
- 6 Form 4 sale TMDXNo planDec 13, 2023 same day
Sold 4,122 shares at $75.10 ($310k)
Provost Miriam, VP, Global Regulatory Affairs
No 10b5-1 planSold 14.1% of holdings ($2.2M position)25,133 shares left1.1x usual sizeFollows a Form 144Filing
- 7 Form 144 notice TMDXNoticeMar 12, 2024 +90 days
Filed to sell 1,815 shares ($152k)
Provost Miriam, Officer
No 10b5-1 plan0.5x usual sizeFiling
- 8 Form 144 notice TMDXNoticeMar 13, 2024 +1 day
Filed to sell 1,248 shares ($106k)
Provost Miriam, Officer
No 10b5-1 plan0.3x usual sizeFiling
Every transaction
Loading transactions…
Sales and notices (9)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Mar 13, 2024 | Mar 13, 2024 | TMDX | Officer | Form 144 notice | 1,248 | $106k | Notice | SEC | |
| Mar 12, 2024 | Mar 12, 2024 | TMDX | Officer | Form 144 notice | 1,815 | $152k | Notice | SEC | |
| Dec 13, 2023 | Dec 15, 2023 | TMDX | VP, Global Regulatory Affairs | Form 4 sale | 4,122 | $310k | 14.1% | No plan | SEC |
| Dec 13, 2023 | Dec 13, 2023 | TMDX | Officer | Form 144 notice | 4,122 | $310k | Notice | SEC | |
| Aug 31, 2023 | Sep 5, 2023 | TMDX | VP, Global Regulatory Affairs | Form 4 sale | 2,708 | $180k | 10.3% | No plan | SEC |
| Aug 31, 2023 | Aug 31, 2023 | TMDX | Officer | Form 144 notice | 2,708 | $180k | Notice | SEC | |
| Dec 13, 2022 | Dec 15, 2022 | TMDX | VP, Global Regulatory Affairs | Form 4 sale | 4,315 | $270k | 22.2% | Plan not stated | SEC |
| Dec 9, 2022 | Dec 13, 2022 | TMDX | VP, Global Regulatory Affairs | Form 4 sale | 3,613 | $213k | 21.0% | Plan not stated | SEC |
| Sep 15, 2021 | Sep 17, 2021 | TMDX | VP of US Regulatory & FDA Rel. | Form 4 sale | 3,877 | $122k | 31.2% | Unusual | SEC |